compliance, cee, europe, regulation, pharma, pharmaceutical, industry, interview, ebook

Download ebook: Compliance Challenges & Conclusions

Predictions and tips to benchmark and drive your compliance programme CEE is regarded as a strong growth market for pharma, but operating in the region comes with its own challenges. In an era of changing social environment and a growing demand for increasing transparency, compliance faces a raft of challenges in this region including working with distributors, managing risk, understanding local …

Teva’s New CEO Moves Quickly on Dealmaking

Recently, pharmaceutical company Teva has been facing numerous challenges. These include expiring patents for their top drugs, strong labour opposition to plans for restructuring, conflict between the Board of Directors and Management which resulted in the CEO’s departure, and shareholder unrest. Eyal Desheh, the CFO, has said that they have to make smart deals and partnerships like how Teva has …

How Long Before We Have the Universal Availability of Insulin

According to the International Diabetes Federation, there are over 371 million people around the world who suffer from diabetes. And yesterday, 14th November, marked 2013’s World Diabetes Day. The day, aimed at raising awareness and support for those suffering from the infliction, saw events take place across the globe and as well as organisations lighting up national monuments blue in …

BMI SYSTEM seminar highlights need for more compliance tools

London, 26th June 2013: BMI SYSTEM held its fourth successful seminar in London entitled "Meetings organisation & public disclosure: what does optimal preparedness look like?" The seminar, hosted in conjunction with Compliant Venues and CWT Meetings & Events, took place at One Wimpole Street and explored recent moves to improve the transparency of relationships between pharmaceutical companies and healthcare professionals …

Download Ebook: Top 5 biggest challenges in Pharma compliance

The increasing number of transparency regulations in Pharma and anti-corruption & anti-bribery laws are beginning to resemble legislation in the United States. The risk of severe fines and a tarnished reputation means companies need to make sure they are managing risk and implementing a comprehensive compliance programme. But what are the key challenges faced by compliance professionals in pharma? From …